Phillip M. Schneider's most recent trade in ARS Pharmaceuticals Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ARS Pharmaceuticals Inc | Phillip M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Longboard Pharmaceuticals Inc | Phillip M. Schneider | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Dec 2024 | 25,461 | 0 | - | - | Employee Stock Option (right to buy) | |
| Longboard Pharmaceuticals Inc | Phillip M. Schneider | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Dec 2024 | 22,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Longboard Pharmaceuticals Inc | Phillip M. Schneider | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Dec 2024 | 12,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Longboard Pharmaceuticals Inc | Phillip M. Schneider | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Dec 2024 | 12,367 | 0 | - | - | Employee Stock Option (right to buy) | |
| ARS Pharmaceuticals Inc | Phillip M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Longboard Pharmaceuticals Inc | Phillip M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| ARS Pharmaceuticals Inc | Phillip M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Longboard Pharmaceuticals Inc | Phillip M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| ARS Pharmaceuticals Inc | Phillip M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 153,647 | 153,647 | - | - | Stock option (right to buy) | |
| ARS Pharmaceuticals Inc | Phillip M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 76,823 | 76,823 | - | - | Stock option (right to buy) | |
| Longboard Pharmaceuticals Inc | Phillip M. Schneider | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 12,367 | 12,367 | - | - | Stock Option (Right to Buy) |